Vor Biopharma, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Vor Biopharma, Inc. - overview
Established
2015
Location
Boston, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, Vor Biopharma, Inc. operates as a biotechnology company founded by Robert Ang. The company develops cell therapy for patients suffering from hematological malignancies. The company has raised a total of USD 152 million in two funding rounds from private equity investors, including 5AM Ventures, Johnson & Johnson Innovation, PureTech Health, and RA Capital.
In March 2026, Vor Biopharma, Inc. raised USD 75 million in a private placement, selling 5. 34 million shares at USD 14. 05 per share, on the NASDAQ.
The company plans to use the March 2026 funding to advance the clinical development of telitacicept, including global Phase 3 trials in myasthenia gravis and primary Sjögren’s disease, and to support business development, working capital, and general corporate purposes.
Current Investors
RA Capital Management, 5AM Ventures, Johnson & Johnson Innovation
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment, Specialty Pharmaceuticals, Pharmaceutical Research & Development
Website
www.vorbio.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Vor Biopharma, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PIPE | Completed | Vor Biopharma, Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.